Appellate Court Upholds Roundup Damages of $20.5M For California Groundskeeper Diagnosed with Non-Hodgkins Lymphoma

A California appeals court has determined that Bayer and its Monsanto subsidiary should pay $20.5 million in compensation to a California groundskeeper who developed non-Hodgkin’s lymphoma from Roundup, rejecting the manufacturers attempt to entirely reverse a lower court verdict.

In August 2018, a California Superior Court jury awarded DeWayne Johnson $289 million in the first Roundup case to go to trial in the United States, delivering a resounding message for Bayer about the liability it faces from Monsanto’s failure to warn consumers about the risks associated with Roundup.

In addition to compensatory damages, the original jury verdict included $250 million in punitive damages, which was intended to punish the company for withholding information about the link between the active ingredient in Roundup, glyphosate, and the risk of non-Hodkins lymphoma.

ROUNDUP LAWSUITS

Were you or a loved one exposed to RoundUp?

Exposure to RoundUp has been linked to an increased risk of developing Non-Hodgkin's Lymphoma and other cancers. RoundUp cancer lawsuits are being actively investigated.

Learn More About this Lawsuit See If You Qualify For Compensation

Following post-trial motions, the judge presiding over the case reduced the Roundup damage award to $78 million, upholding the full amount of the $38 million in compensatory damages awarded, but reducing the punitive award to $50 million.

Since the verdict, Bayer has been seeking to overturn the decision, continuing to maintain that Roundup is safe and does not cause non-Hodgkins lymphoma. However, following a string of subsequent losses at trial and facing more than 125,000 Roundup lawsuits being pursued by former users of the weedkiller, Bayer recently announced an agreement to pay more than $10 billion to resolve about two-thirds of the litigation.

While the individual Roundup settlements are proceeding, Bayer has continued to pursue an appeal of the verdict in the Johnson cases, as well as other losses at trial.

Bayer has attempted to argue that the trial verdicts should be overturned since the U.S. Environmental Protection Agency (EPA) reviewed and approved the Roundup warning label, indicating that should make the company immune from liability for failing to warn consumers. However, the recent ruling by a California appeals court in San Francisco rejected that argument.

Although the total amount of damages awarded to Johnson was further reduced to about $20.5 million, the ruling by the appellate court results in another failure of Bayer to convince any court that they should not be required to compensate former users of Roundup diagnosed with non-Hodgkins lymphoma.

The ruling is likely to further increase pressure on Bayer to negotiate settlements in thousands of cases that remain unresolved. However, the company is also likely to face years of future litigation over failure to warn about the risks associated with Roundup, as former users may continue to develop non-Hodgkins lymphoma for years in the future.

0 Comments

Share Your Comments

I authorize the above comments be posted on this page*

Want your comments reviewed by a lawyer?

To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.

NOTE: Providing information for review by an attorney does not form an attorney-client relationship.

This field is for validation purposes and should be left unchanged.

More Top Stories

Uber Driver Sexual Assaults and Misconduct Reports Must Be Disclosed in Lawsuit Discovery
Uber Driver Sexual Assaults and Misconduct Reports Must Be Disclosed in Lawsuit Discovery (Posted today)

A federal magistrate judge is forcing Uber to hand over potentially hundreds of thousands of incident files involving reports of passengers who suffered sexual misconduct or sexual assault at the hands of the rideshare service's drivers.

Abbott May Remove Infant Formula for Preemies Off the Market Due to Similac NEC Lawsuits
Abbott May Remove Infant Formula for Preemies Off the Market Due to Similac NEC Lawsuits (Posted yesterday)

Abbott Laboratories is considering removing Similac infant formula products designed for preterm babies from the market, as it faces hundreds of lawsuits claiming the products increase the risk of necrotizing enterocolitis, which puts newborns at a high risk of permanent injuries and death.

Information About Suboxone Dental Claims To Be Exchanged By Parties in MDL
Information About Suboxone Dental Claims To Be Exchanged By Parties in MDL (Posted 2 days ago)

A federal judge has ordered parties involved in Suboxone dental decay lawsuits to submit proposals for exchanging information that will guide the selection of representative bellwether claims for early test trials.